Publications

The rare-to-common disease journey: a winding road to new therapies

 146
The rare-to-common disease journey: a winding road to new therapies

Tags:

Previous Article

How Pseudomonas aeruginosa evade antibiotic therapy?

Next Article

Connecting rare-to-common disease to therapies

Related Posts

Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1

Oligodendrocyte dysfunction contributes to motor defici...

 72

Oligodendrocyte-derived laminin-g1 regulates the blood-brain barrier and CNS myelination in mice

Oligodendrocyte-derived laminin-g1 regulates the blood-...

 119

Mapping clinical CAR-T cells: insights from scRNA-seq

Mapping clinical CAR-T cells: insights from scRNA-seq

 86